Spanish Court Deals Blow To Merck In Zocor Patent Suit

Law360, New York (April 19, 2004, 12:00 AM EDT) -- A Spanish court has ruled in favor of a unit of Bentley Pharmaceuticals, dealing Merck & Co. another blow in its attempt to protect its anti-cholesterol blockbuster drug Zocor from generic protection in Spain.

Earlier this month, the court ruled in favor of Laboratorios Belmac, Bentley’s Spanish subsidiary in Merck’s patent lawsuit against the company, ordering Merck to pay all of Laboratorios Belmac's legal costs without limitation.

Zocor is the world's second-largest selling drug, behind Lipitor, with $6.1 billion in sales. The U.S. patent on Zocor...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.